-
Cerus Europe BV
- General Manager
2016 - maintenant
Cerus Europe BV is a subsidiary of Cerus, Inc. based in Concord – California (USA)
We commercialize INTERCEPT product line, for the inactivation of Pathogens in blood components, throughout the region Europe - Middle-East and Africa, as well as in Russia and CIS.
-
Thermo Fisher Scientific - Clinical Diagnostic Division (Brahms)
- Vice President Global Sales and Marketing
2010 - 2015
Employed by BRAHMS GmbH, subsidiary of TFS since 2009; specialized in Biomarkers.
Worldwide responsibility for the Commercial activities: (Sales, Marketing, Field Service, Customer Service) of the Diagnostic Division of Thermo Scientific ($800M).
Nine Directors reporting in direct line and 3 reporting in dotted line, leading a commercial organization of 530+ people throughout the world. Revenues over $600M of which $500+M are direct sales. In addition network of distributors (over 100) in Middle-East/Africa, Latin America and South East Asia.
Business served: Biomarkers, Specialty Diagnostic: Toxicology, Therapeutic Drug Monitoring, ISD, Controls, Clinical Chemistry; Industrial applications. Organic Growth from 2 to 20+%, according the business; division grows in average 7 to 8% per annum. Main customers are: Hospitals (ED/ICU/Central lab), Forensic labs, Pharmaceutical, Food & Beverage-Breweries, Academics, Environment labs, etc...
-
Thermo Fisher Scientific
- Vice President Global Sales & Marketing - Clinical Diagnostic Division
VILLEBON SUR YVETTE
2010 - 2015
-
Thermo Fisher Scientific / BRAHMS Biomarkers GmbH
- Directeur des opérations commerciales
2010 - maintenant
BRAHMS est une Business Unit de la Division Clinical Diagnostic de Thermo Fisher.
En tant que responsable des opérations commerciales(Marketing, Ventes, Support Clients, Distribution internationale)au niveau mondial, je supervise les filiales Européennes qui commercialisent nos produits en direct, ainsi qu'un réseau de distribution internationale dans plus de 60 pays.
-
Novartis Vaccine and Diagnostic Division
- Vice President & General Manager EMEA
2006 - 2010
Responsible for developing the Blood Testing Business, in EMEA, for the Diagnostic- US-based- operating division.
Responsible for overall strategic business development, including direct P&L accountability for $145M+ revenue, and managing nine direct reports as part of directing a global team of over 100.
Oversaw an 18% CAGR in revenue, over the last three year.
Maintained repetitively business in major European countries and recently captured 100% of the French Blood Testing market for a 4 years period, as well as renewed 100% of the South African market for another 5 years.
Expanded business in the Mideast through local distributors.
-
Novartis Vaccines & Diagnostics SAS
- VP Diagnostic Commercial Operations EMEA
2006 - maintenant
-
Ventana Medical System
- Vice President and General Manager EMEA
2003 - 2006
Direct P&L accountability for $60M revenue of an international subsidiary of one of the 100 fastest growing US small companies per Business Week.
Responsible for the overall strategic business development and daily operations from headquarters in Strasbourg, France. Five direct reports and a global headcount of 120 people.
• Outstanding revenue growth (+ 45%) without any new products.
• Improved profitability (Operating Income from 13% of sales to 33% in two years).
• Optimized all company processes and implemented a Quality Management System in 12 months and obtained ISO certifications 9001 and 13485.
• Improved global teamwork through project prioritization, communication and inter-department coordination. Overall productivity increased by 10% in one year.
-
bioMérieux Austria GmbH
- Managing Director
1999 - 2003
Used the Austrian commercial platform and organization, to successfully develop business across Central and Eastern European markets.
Full operational and P&L responsibility for an organization including 43 peoples, with 16 located at branch offices in Prague, Budapest and Belgrade, and additionally managed a distributor network covering a further 10 other countries.
• Directed strong sales growth (20+% CAGR); export activity reached 50% of the €20M revenues.
• Managed merger of subsidiaries in Austria after the acquisition of Organon Teknika.
-
bioMérieux Italia sarl.
- Commercial Director Italy
1998 - 1999
Applied strong leadership, organizational and business skills to achieved structural reorganization and ensured company growth for the long term.
• Plan was met despite all difficulties; resulting in sales of €40 Million and 7 % + growth.
-
bioMérieux Canada, Inc.
- Managing Director Canada
1993 - 1998
Led the creation and incorporation of a new Montréal-based company including establishing complete commercial organization, together with support functions; in order to develop local sales and reach full autonomy to better serve the customers.
• Company grew to 30 employees and $10M in revenue by 1998.
-
bioMérieux USA
- Marketing Manager Diagnostic
1991 - 1993
Responsible for building the bioMérieux image and launching as many bioMérieux, French-made products, as possible into the market. Contributed to the registration of 15 products at the FDA. Additionally, studied the feasibility of launching a semi-automated system for bacteriology.
-
API International SA/ bioMerieux International
- Technical Assistant and Area Manager
1986 - 1990
Supported a commercial network of distributors in 27 countries (Asia pacific, Europe, South Africa) including
training and delivery of local seminars, to promote products and systems. Total revenues: 14M SFr.
Developed and conducted series of local seminars/workshops across multiple countries to support the launch of an automated microbiology system
-
API SYSTEM Suisse
- Sales Representative & Product Specialist
1983 - 1986
Sold systems to 400 labs in Switzerland; resulting in sales of 2M SFr. Provided training and technical support to clients and distributor outside of Switzerland.
-
API SYSTEMS
- Training Officer
PORTE-DE-SEINE
1980 - 1983
Developed, organized and ensured technical training for customers, distributors and employees.
